ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

EHC vs THC // EV/EBITDA & P/E VALUATION

Encompass Health Corporation (NYSE) VS. Tenet Healthcare Corporation (NYSE) • 15-METRIC TALLY: EHC 5 — THC 8
▲ EV/EBITDA & P/E VALUATION LEADER: THC
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EHC VS. THC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC EHC THC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 13.80% 27.60% -13.80 THC /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 15.8x 6.3x +9.50 THC /valuation <GO>
Free Cash Flow Yield 2.92% 11.61% -8.69 THC /fcf-yield <GO>
Operating Margin 11.60% 16.50% -4.90 THC /operating-margins <GO>
Net Profit Margin 9.50% 11.10% -1.60 THC /net-margins <GO>
Revenue Growth (YoY) 10.50% 3.10% +7.40 EHC /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.55% 0.00% +0.55 EHC /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.47 2.08 +1.39 EHC /balance-sheet <GO>
Piotroski F-Score Quality 9/9 6/9 +3.00 EHC /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 60.3 54.8 +5.50 EHC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.90 0.97 -0.07 THC /macro-sensitivity <GO>
Forward P/E Multiple 21.3x 8.6x +12.70 THC /forward-pe <GO>
Enterprise Scale & Market Cap $12.97B $21.79B -$8.81B THC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR EHC REV THC REV EHC GROSS % THC GROSS % EHC FCF THC FCF
FY 2025 $5.94B $21.31B — — — $2.53B
FY 2024 $5.37B $20.68B — — — $1.12B
FY 2023 $4.80B $20.56B — — — $1.45B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EHC // BETA 0.90
THC // BETA 0.97